Randomized Controlled Trial of Silymarin in Asthma
Status:
Withdrawn
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if intake of the antioxidant enzyme inducer,
silymarin, will improve lung function and symptom scores in participants with asthma.